Ngai Hang Victor Chong - Mar 18, 2024 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
CLSD
Transactions as of
Mar 18, 2024
Transactions value $
$0
Form type
4
Date filed
3/18/2024, 05:20 PM
Previous filing
Mar 18, 2024
Next filing
Mar 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Employee Stock Option (right to buy) Award $0 +450K $0.00 450K Mar 18, 2024 Common Stock 450K $1.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares underlying this option vest on March 18, 2025 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.